Home » Topics » BioWorld Science

BioWorld Science
RSS

Medinox and PUMC to develop NOX-100 in China and South Korea

Aug. 18, 2004

Cangene plans new anthrax project

Aug. 18, 2004

New TACE inhibitors and their use covered by Vertex patent

Aug. 18, 2004

FDA and Genentech issue warning on Avastin

Aug. 18, 2004

New HSP90 inhibitors and their use in cancer and other disorders

Aug. 18, 2004

Alpharma presents new 10-modified erythromycins and their use as antibacterial agents

Aug. 18, 2004

Novel oxazolidinone-based antibacterial agents under study at AstraZeneca

Aug. 18, 2004

Selective neutral endopeptidase inhibitors reported by Pfizer scientists

Aug. 18, 2004

Three series of chemokine CCR5 modulators claimed by AstraZeneca

Aug. 18, 2004

Swiss approval for Femara as extended adjuvant treatment

Aug. 18, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...
AACR D3: ONM-421 shows antigen-independent tumor control
BioWorld Science
At the American Association for Cancer Research’s inaugural Drug Discovery and Development conference (AACR D3), Onconano Medicine Inc. presented preclinical data...